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Abstract | Tissue and organ biology are very challenging to study in mammals, and progress 
can be hindered, particularly in humans, by sample accessibility and ethical concerns. 
However, advances in stem cell culture have made it possible to derive in vitro 3D 
 tissues called organoids, which capture some of the key multicellular, anatomical and even 
functional hallmarks of real organs at the micrometre to millimetre scale. Recent studies have 
demonstrated that organoids can be used to model organ development and disease and have 
a wide range of applications in basic research, drug discovery and regenerative medicine. 
Researchers are now beginning to take inspiration from other fields, such as bioengineering, 
to generate organoids that are more physiologically relevant and more amenable to real-life 
applications. 
 
 
 
Over the past few decades, a large body of work generated by developmental and stem cell 
biologists has provided an understanding of how to control stem and progenitor cell 
behaviours, such as self-renewal and differentiation along specific tissue lineages, at a 
molecular level. At the same time, research in the field of regenerative medicine has shown 
that organs can be repaired by dissociated stem cells that differentiate into one or more of 
the required mature cell types1. Taken together, these developments helped to cultivate the 
idea that stem cells could be used to re-create organs in vitro. Indeed, the past decade has 
seen a marked shift towards the use of organoids for studying tissue and organ biology2–4. 
Nevertheless, the history of organoids could be considered to date back to the 1970s, when 
Howard Green and his colleagues demonstrated that co-cultures of primary human 
keratinocytes and 3T3 fibroblasts form stratified squamous epithelial colonies resembling the 
human epidermis, with cell proliferation in the basal layers and keratinization in the upper 
layers5. However, similar to traditional mammalian cell culture, this and many subsequent 
approaches involved growing cells on artificial 2D surfaces, which precludes the study of 
behaviours that are intrinsically linked to the 3D organization of cells into tissues and organs. 
The establishment of 3D culture systems, which resulted from a better understanding of 
extracellular matrix (ECM) biology6,7 and the development of methods for culturing cells in 
suspension8,9, played a key part in enabling organoid culture. Among the first examples of 
what today might legitimately be considered an organoid were structures derived from the 
mammary gland by Mina Bissell and colleagues, which showed that in vitro morphogenesis 
could be observed in 3D laminin-rich matrices10,11. These cultures resulted in functional 
alveolus-like structures characterized by epithelial polarization and directional secretion, 
which developed by virtue of their interaction with the basement membrane10. However, it 
was perhaps the groundbreaking work by the groups of Yoshiki Sasai12 and Hans Clevers13 
that kick-started the organoid field. Clevers and co-workers demonstrated that intestinal 
organoids13 could be derived from intestinal adult stem cells (ASCs) whereas Sasai and 
colleagues showed that pluripotent stem cells (PSCs) could be used to recapitulate in vitro 
the development of cortical tissues14 and the optic cup12. Their work promoted the idea that 
stem cells have the intrinsic ability to self-organize into 3D structures that resemble in vivo 
organs, which remains one of the cardinal concepts underlying organoid biology. Subsequent 
to these pioneering studies, other scientists have succeeded in generating organoids from a 
wealth of different cellular sources and from different species (Table 1). 
Over the years, the term organoid has been used to define different types of in vitro cultures, 
from tissue explants15–17 to organ-on-chip systems18, with the general meaning being 'similar 
to an organ'. However, this broad definition may lead to confusion19. In this Review, we 
consider organoids to be complex 3D structures that display architectures and functionalities 
similar to in vivo organs and that develop from stem cells or organ-specific progenitors 
through a self-organization process2,3. Here, we describe the main classes of organoids and 
how they can be derived and discuss their existing and emerging applications in the fields of 
basic biology, disease modelling and regenerative medicine. We highlight some of the key 
challenges that the field is encountering and provide a forward-looking framework for how 
multidisciplinary approaches could be used to build next-generation organoid platforms. In 
particular, we take inspiration from tissue engineering20, a field classically focused on the 
design and fabrication of biocompatible materials that serve as cell-instructive scaffolds for 
tissue reconstruction. Tissue engineers have conceived a wide range of technologies to 
augment tissue regeneration that could further improve organoid cultures. We do not discuss 
in detail specific organoid types or their applications in specific fields and instead refer 
interested readers to several excellent recent reviews on these topics21–26. 
 
 
Deriving organoids 
 
Organoid development usually involves the self-organization of a fairly homogeneous cell 
population. Selforganization can be defined as the capacity of a cellular system that initially 
lacks an ordered structure to spatially rearrange under the guidance of system-autonomous 
mechanisms, even if exposed to a uniform signalling environment4. Much of what is known 
about this process comes from decades of research in the field of developmental biology. 
Conceptually, the self-organization process can be broken down into self-patterning events 
and morphogenetic rearrangements4. 
Self-patterning is the formation of patterns of cell differentiation in an initially homogeneous 
system that result from system-autonomous mechanisms and local intercellular 
communication. Self-patterning usually starts with a symmetry-breaking event4,27, for which 
interplay between a number of different mechanisms has been proposed, including reaction-
diffusion mechanisms28,29, bistability of regulatory networks30 and asymmetric cell division4. 
Many of these mechanisms rely on positive and negative feedback circuits and crosstalk 
between them28–30. Morphogenetic rearrangements result from sorting of different cell types 
within a tissue and from higher-level reorganization of the system’s architecture. Cell sorting 
is mediated by physical interactions between different cell types, which involve differences in 
cell–cell adhesion, cortical tension and/or contractility and cell motility4,31. Architectural 
rearrangements are sustained by system-intrinsic mechanics resulting from changes in cell 
shape, cell contraction, cell movement or differential tissue expansion4. Successful derivation 
of organoids relies on recapitulating these processes and requires careful consideration of 
three main features: the physical characteristics of the culture environment; the requirement 
for system-autonomous (that is, endogenous) and/or exogenous signals; and the starting cell 
type and system conditions. Choices made regarding each of these features can affect the 
characteristics of the final organoid. 
 
Physical characteristics of the culture environment. 
The most common way to promote the 3D characteristic of organoids is to use solid ECMs 
that support cell growth and to which cells can adhere (Fig. 1a). Matrigel, a natural ECM 
purified from Engelbreth-Holm-Swarm mouse sarcoma7, is the most widely used matrix for 
3D organoid derivation. Intestinal13, cerebral32, gastric33 and mammary gland17 organoids are 
only some of the examples that have been successfully generated using Matrigel or similar 
animal-derived hydrogels that mimic basement membranes. There have also been some rare 
examples of the use of collagen type I matrices for derivation of mammary gland34 and 
intestinal35 organoids. The main advantage of these natural matrices is the presence of a 
complex mix of ECM components and growth factors, which makes cell growth and 
differentiation very efficient. However, this complexity and the variability in composition 
make it more difficult to control the culture environment and may lower reproducibility. For 
these reasons, chemically defined hydrogels have been recently introduced to support 
intestinal36 and cerebral37 organoid culture as a substitute for the less well-defined natural 
matrices. These hydrogels allow the biochemistry and mechanics of the culture environment 
to be controlled but are inherently less bioactive and need to be customized to match the 
specific requirements of different organoids. 
A different strategy, which has been adopted for the derivation of optic cup12, cerebral14, 
cerebellar38 and hippocampal39 organoids, is the culture of 3D cell aggregates in suspension 
(Fig. 1a). Although the suspension culture approach does not make use of a solid scaffold for 
cell embedding, in some cases low concentrations of Matrigel are added to promote the 
formation of polarized epithelial structures12. 
Kidney organoids40,41 have been generated using an air–liquid interface method in which cells 
are cultured in the form of a pellet on a thin, microporous membrane, with cell culture 
medium only on the basal side of the membrane (Fig. 1a). Cell pellets subsequently self-
organize into a multi-layered structure that resembles the microarchitecture of the native 
kidney. 
At this point in time, the decision to use a specific organoid derivation protocol is largely 
driven by empirical considerations. Indeed, systematic comparisons of different protocols for 
deriving a specific organoid type are lacking, which means it is not yet possible to appreciate 
the relative strengths, weaknesses and applications of each protocol. 
 
Endogenous and exogenous signals. 
Most organoids are derived from a starting cell population that has been exposed to specific 
morphogens at defined time points, which results in the activation of desired developmental 
signalling pathways. In turn, these signals can trigger self-organization, but only if all the 
necessary components are present in the system: missing components must be provided 
exogenously for self-organization to proceed appropriately. 
The derivation of some organoids relies almost exclusively on endogenous signals (Fig. 1c). 
For example, mouse optic cup organoids are derived from mouse PSCs that are aggregated 
and cultured in a serum-free medium containing low levels of growth factors. These 
conditions support the formation of a uniform neuroepithelium (NE), after which self-
patterning mechanisms specify spatially separated domains of neural retina (NR) and retinal 
pigmented epithelium (RPE) (Fig. 1c). Morphogenesis then also proceeds without 
exogenously provided signals12. Thus, the starting cell population already possesses all the 
required components to self-organize into an optic cup, likely following its default 
developmental trajectory. Nevertheless, it should be noted that although no additional 
factors are supplied during derivation of these organoids, it is possible that a small quantity 
of exogenous signals could be present in the minimal amount of Matrigel used in the 
procedure. 
The majority of organoid derivation protocols do require that specific exogenous signals are 
provided because the initial cellular system does not contain all the essential components to 
undergo the desired self-organization process. In some cases, exogenous signals are 
necessary only for induction of initial cell types, which then rely on system-autonomous 
signals to undergo the remaining steps of self-organization. For example, human PSCs (hPSCs) 
must be exogenously stimulated with specific growth factors to form a mixed population of 
ureteric epithelium and metanephric mesenchyme cells40, which will then self-organize into 
kidney organoids without addition of further factors to the medium25,40 (Fig. 1c). 
Finally, for many organoids, the cellular system must be stimulated with appropriate and 
specific exogenous signals throughout the derivation process. hPSC-derived gastric organoids 
are just one of several such examples: exogenously supplied factors are necessary to push 
hPSC-derived definitive endoderm cells towards a posterior foregut fate33 (Fig. 1c); further 
exogenous stimulation is then required to guide cells towards an antral or fundic gastric 
epithelial fate and to direct growth, morphogenesis and differentiation into functional gastric 
cell types33,42. 
Although these considerations apply to all types of organoids, PSC-derived organoids in 
particular often require timed exposure to specific factors to guide the system through the 
desired developmental trajectories. The decision on which specific factors to use, and when 
they are applied, is generally informed by the current understanding of relevant in vivo 
developmental mechanisms. 
 
Starting cell type and initial culture conditions. 
Protocols for the derivation of different organoids vary in the starting state of the cell 
population (Fig. 1b). Depending on the initial conditions, a cell ensemble will undergo all or 
only some of the steps involved in self-organization. When organoids are derived from a single 
cell type (as is the case for optic cup or small intestine organoids), self-organization of the cell 
population necessarily involves symmetry-breaking and subsequent patterning to generate 
spatially separated domains of different cell types. This patterned structure can then undergo 
morphogenetic rearrangements to acquire the final organoid architecture. In general, when 
an organoid derivation protocol starts from a single cell, an early step of cell expansion is 
required before self-organization can occur. At the opposite end of the spectrum, there are 
protocols that involve the co-culturing of cell types that have been separately pre-
differentiated, which is the case for PSC-derived liver organoids43. In these protocols, the 
disparate cell identities are to a large extent already established; therefore, self-organization 
primarily involves cell sorting and subsequent architectural rearrangements (Fig. 1b). The 
initial conditions of the cell population will also affect the range of applicability of an organoid 
as a biological model system. Indeed, organoids obtained through the co-culture of separately 
pre-established cell types are arguably less informative for studying organogenesis than 
models in which the different cell types are generated simultaneously and therefore have the 
potential to capture more comprehensively the transient developmental interactions that 
could occur between different progenitors during the formation of the organoid. 
The characteristics of the final organoid also depend on the starting cell type. Organoids have 
been derived from ASCs13,17,34,44 (either as isolated cells or from dissected tissue fragments), 
PSCs12,32,33,45 or fetal progenitor cells46,47. Some types of organoids have thus far been derived 
only from PSCs, including neuroectodermal organoids, such as optic cup12 and cerebral 
organoids14,32, and mesodermal kidney organoids40,48. By contrast, organoids of surface 
ectoderm lineage (particularly glandular tissues) have been mainly derived from ASCs or 
dissociated adult tissues34,49–51. The majority of organoids of the endodermal lineage have 
been derived from both PSCs and ASCs (Table 1). Terminally differentiated cells 
reprogrammed to a tissue-specific ASC-like state have recently been used as an alternative 
source for derivation of epithelial mammary gland and pancreatic organoids52. Only a few 
examples of organoids derived from fetal progenitors have been published. Pancreatic 
organoids have been derived using cells dissociated from mouse fetal (embryonic day 10.5) 
dorsal pancreata47 and fetal-type intestinal organoids have been obtained from dissociated 
human fetal intestinal tissue46. 
Because different cell types originate from distinct developmental stages, they will follow 
different paths Fig. 2); therefore, the choice of the starting cell population is particularly 
important when studying mechanisms underlying organoid formation. Organoids derived 
from ASCs or adult tissue fragments are believed to mimic the homeostatic or regenerative 
conditions of their tissue of origin2. Thus, stem cells from organs that are characterized by 
continuous renewal throughout life, such as the epithelia of the small intestine13, colon53 or 
stomach54,55, generate organoids representing the homeostatic role of these cells in vivo. By 
contrast, organoids derived from tissues with a slow turnover2 in which endogenous stem 
and/or progenitor cells presumably play a role only upon injury, such as in the pancreas or 
liver, are considered to be bona fide models of regeneration56,57. Although this classification 
is clear in vivo, in vitro conditions can make the distinction between homeostasis-driven and 
regeneration-driven organoids tricky to determine. For example, it has been reported that 
intestinal organoid formation occurs through mechanisms that seem to be unnecessary for 
homeostasis in vivo but are activated under regenerative conditions58. Similarly, gastric 
organoids can be obtained from a starting population of cells that specifically expands in vivo 
upon injury44. 
While ASC-derived organoids are useful for answering questions about adult tissue biology, 
PSC-derived organoids are mainly used to study organogenesis and developmental events 
that lead to tissue formation (Fig. 2). PSC-derived organoids very rarely reach an adult tissue 
stage in vitro and usually resemble fetal-stage tissues12,33,45 (Fig. 2). One possible reason for 
the limited maturation of PSC-derived organoids is the fact that development towards more 
mature cell types requires continuous culture for periods of time that typically exceed the 
capacity of the actual culturing methodologies59. Another possibility is that, in contrast to 
ASC-derived organoids, cells in PSC-derived organoids are missing crucial interactions with 
other co-developing cell types because of our limited capacity to fully reconstruct embryonic 
developmental processes in vitro60. 
So-called embryonic organoid systems can be used to build more complete developmental 
models in vitro. These self-organizing PSC-derived structures, also termed ‘embryoids’ or 
‘gastruloids’, mimic in a very simplified way pre-implantation61 and early post-implantation 
embryonic development62–64, establishment of body axes65,66, gastrulation65–71 and neural 
tube development72,73. Whereas classic organoids are typically composed of a restricted 
subset of cell types from one germ layer, embryonic organoids are characterized by the 
coexistence of cells from multiple germ layers, as in real embryos. This feature adds a 
fascinating level of complexity and allows for the reproduction and in vitro study of the 
intricate interactions among different cell types in developmental processes. 
Finally, fetal progenitor-derived organoids46,47 start directly from fetal tissues, thus from a 
stage between ASCs and PSCs. Therefore, fetal organoids can be used to study more advanced 
stages of organogenesis than PSC-derived organoids. For example, enterospheres from fetal 
intestinal progenitors have been used to study their maturation towards adult intestinal 
organoids46. 
 
 
Applications of organoids 
 
Organoids as models of development, homeostasis and regeneration. 
Organoids recapitulate in vitro some principles of organ biology and provide simplified and 
readily accessible ‘minimal systems’ for discerning the relative contribution of different tissue 
components to complex morphogenetic processes (Fig. 3a). Indeed, organoids have already 
revealed surprising mechanisms of tissue-autonomous self-organization in homeostasis, 
regeneration and development. These tissue-autonomous mechanisms would have been 
difficult to identify in vivo because of the potentially confounding influences of nearby tissues. 
For instance, in ASC-derived intestinal organoids, stem cells isolated from crypts re-establish 
an intestinal epithelium in the absence of a subepithelial mesenchymal compartment13, and 
in PSC-derived optic cup organoids, optic vesicles autonomously undergo morphogenesis 
without the need for signals from an overlying surface ectoderm12. 
A key feature of organoids is their greater experimental accessibility than mammalian animal 
models, which has contributed to a more in-depth understanding of organogenesis and adult 
organ biology. The capacity of mouse intestinal stem cells (ISCs) that express the Lgr5 gene to 
form self-renewing colonies has been shown to be dependent on Paneth cells, a neighbouring 
cell type of ISCs in the crypt74. Indeed, Paneth cells express high levels of WNT ligands, and 
WNT signalling is essential for ISC maintenance75. An elegant study used cells expressing a 
tagged WNT isoform to gain insights into the role of WNT gradients in intestinal biology76. The 
use of intestinal organoids in this study provided an experimentally amenable system to 
generate high-resolution information76. This work demonstrated that the WNT protein does 
not diffuse but is instead transferred from a Paneth cell to an adjacent ISC, and the WNT 
gradient is formed along the crypts by ISC division and dilution of membrane-bound WNT in 
daughter cells. Taken together, these observations indicate that Paneth cells act as localized 
sources of WNT signals for ISC self-renewal76 and support a model in which spatial 
confinement of Paneth cells to the bottom of the crypt defines the physical separation 
between ISC self-renewal and differentiation. This physical separation was previously 
suggested by clonal analysis experiments on ISCs in vivo, which demonstrated that 
competition for occupancy of the crypt niche determined whether ISCs self-renewed or 
differentiated77. 
Similarly, experiments possible only on optic cup organoids have provided insights into the 
mechanisms underlying optic cup morphogenesis, a process that involves invagination of the 
NR within the RPE. Treating mouse organoids at different phases of the conversion from optic 
vesicle to optic cup with drugs that inhibit either active cytoskeletal contraction or cell 
proliferation showed that optic cup morphogenesis is a multi-phase process. The process of 
vesicle invagination starts with domain-specific changes to mechanical properties, which are 
caused by cytoskeletal re-organization. These changes result in a reduction of contractility 
and thus rigidity in the NR and maintenance of high levels of contractility and rigidity in the 
RPE. In subsequent phases, the role of cell proliferation becomes or differences between 
humans and other species. For example, mouse embryos lacking the β-catenin gene, which 
encodes the core transcription factor of the WNT pathway, show a loss of fundic stomach 
identity and an expansion of the antral domain42. This result suggests a prominent role for 
WNT signalling in specifying fundic identity. To determine whether this might also be the case 
in human gastric patterning, hPSC-derived gastric organoids33 at the posterior foregut stage 
were exposed to a WNT agonist, and expression analysis of domain-specific markers 
confirmed a switch from antral to fundic identity42. 
Whereas gastric organoids highlight common developmental mechanisms between humans 
and mice, optic cup organoids underline human-specific developmental features12,78. Indeed, 
human optic cup organoids take much longer than their mouse counterparts to reach 
comparable developmental stages. They are also larger and have a thicker NR than mouse 
organoids. These species-specific differences are confirmed by the analysis of human and 
mouse embryonic tissues78. Moreover, optic cup organoids have revealed species-specific 
morphogenetic mechanisms. Normally, during the progression from optic vesicle to cup, the 
NR changes from an apically concave to an apically convex structure. In mouse organoids, this 
so-called eversion requires continuity between the NR and the RPE. Indeed, mouse NRs 
dissociated from the RPE at the vesicle stage do not undergo eversion12,78. By contrast, human 
NRs dissociated from the RPE at the vesicle stage are still able to autonomously undergo 
eversion through a myosin-independent mechanism mediated by integrins78. 
Finally, organoids can be used as minimal systems to study the principles of self-organization. 
An interesting example comes from research on embryonic organoid models of gastrulation 
(gastruloids)66–71. In these systems, cells adopt spatially organized fates as a result of uniform 
exposure to a morphogen, which implies they self-organize65,67,69–71. In some of these studies, 
a combination of in silico mathematical models and experimental data has been used to test 
the capacity of specific molecular mechanisms to recapitulate the outcome of self-
organization67,70. These models were then used to successfully predict the behaviour of 
gastruloids in response to varying the starting conditions67,70. In general, mathematical 
modelling could help to elucidate the mechanisms underlying self-organization and to predict 
the effect of different conditions on the outcome, thus increasing our ability to control 
complex multicellular behaviours in vitro. 
 
Organoids for disease modelling, drug discovery and personalized medicine. 
An obvious advantage of organoid cultures for disease modelling, compared with traditional 
cell cultures of a single cell type, is their ability to mimic pathologies at the organ level (Fig. 
3b). Moreover, organoids derived from human ASCs or induced PSCs (iPSCs) can serve as 
models for human diseases by recapitulating specific human features that are relevant for 
translational studies. A wide range of organoid-based disease models that reproduce genetic 
diseases32,79–81, host–pathogen interactions33,55,82–94 or cancer21,55,95–98 have already been 
developed and provide proof of principle that organoids can reproduce certain well-known 
pathological features (Fig. 3b). For example, human gastric organoids microinjected with 
Helicobacter pylori bacteria successfully reproduce the typical signs of this bacterial 
infection33,55. This model is particularly relevant because species-specific features of the 
stomach make animal models unsuitable for studying human gastric pathologies. Indeed, H. 
pylori infection in mice does not progress to ulceration and cancer as it does in humans55. 
The idea that organoids can model human pathologies has opened the door to studies on the 
feasibility of drug testing and screening applications (Fig. 3c). For instance, drugs for treating 
Zika virus infections were recently screened in hPSC-derived cortical neural progenitor cells 
and validated in parallel in organoids and mouse models, confirming that organoids are a valid 
alternative system for testing drugs against this pathology99. Pioneering results have also 
been reported for the use of organoids in testing drugs for cystic fibrosis (CF), a genetic 
disease caused by defects in the CFTR gene100. Patient-derived intestinal organoids carrying 
CFTR mutations possibly represent the only example of organoids that have already been 
applied to personalized medicine (Fig. 3d). Organoids derived from one patient with a very 
rare CFTR mutation with no known treatment were used to screen existing CF drugs. They 
showed responsiveness to a drug already used to treat other CF mutations, thereby allowing 
the patient access to treatment with beneficial outcomes101. The screen used a standardized 
functional test based on cAMP-induced organoid swelling as a readout for restored CFTR 
functionality, which was optimized on intestinal organoids from both mice and patients for at 
least five different mutations79. Another milestone in the use of organoids for drug screening 
is the development of organoid-based high-throughput screening (HTS) paradigms. An 
interesting example of HTS has been recently reported for human kidney organoids102, in 
which automated organoid derivation and assessment of drug effects have been 
demonstrated. 
An emerging application for organoids is the creation of organoid biobanks for different 
pathologies (Fig. 3c). Such biobanks will eventually facilitate the design of powerful screening 
platforms that cover a wide range of the worldwide population genetic variance. For example, 
the creation of CF intestinal organoid biobanks103 could potentially cover most of the 
spectrum of CFTR mutations. The generation of biobanks could be even more important for 
cancer, a class of pathologies that are characterized by a virtually unlimited number of 
mutations104,105. Cancer cells have been used to generate in vitro structures in a similar 
fashion to organoids. However, these structures, just like the tumours from which they are 
derived, often lack the typical architectural organization of organoids21,53,95–97. These models 
are usually defined as cancer organoids or, perhaps more appropriately, ‘tumouroids’. Initial 
attempts have been made to establish tumouroid biobanks for colon cancer104,105, which is 
very common in humans. One study generated a biobank of primary colon cancer organoid 
lines from 20 patients that preserved the histopathological and main genetic features of the 
original tumours. Furthermore, a proof-of-concept drug screen showed that the drug 
responses of organoids with different mutations matched prior clinical observations105. 
Another group developed a biobank of 55 different colorectal tumouroids representing 
different histological subtypes and clinical stages104. The number of tumouroid biobanks is 
rapidly increasing: a biobank of gastrointestinal cancer organoids was recently used to 
compare patient clinical responses to drugs with in vitro responses106, thereby highlighting 
the predictive potential of cancer organoids, and a library of 22 patient-derived bladder cancer 
organoids has been established that recapitulate the histopathological and molecular 
hallmarks of the respective parental tumours107. 
Organoids from patient-derived iPSCs could also be used to study pathologies for which 
defined genetic causes have not yet been discovered. Complex pathologies with high patient-
to-patient variability might be good candidates for these studies. Indeed, new biological 
insights into autism spectrum disorder (ASD) were recently generated by modelling ASD in 
brain organoid cultures; this approach uncovered in part a pathogenic mechanism that 
involves overproduction of GABAergic neurons in response to FOXG1 overexpression108 (Fig. 
3b). 
All these results are highly encouraging and suggest that organoids could reduce the amount 
of required animal testing in accordance with the 3R principles109. 
 
Regenerative medicine. 
Organoids are emerging as a promising source of transplantable tissues and functional cell 
types for cell therapy in regenerative medicine (Fig. 3e). Proof-of-concept experiments have 
already been reported in animal models. For example, retinal sheets have been derived from 
mouse embryonic stem cells (ESCs) or mouse iPSCs using a modified optic cup organoid 
protocol12 and transplanted into a mouse model of retinal degeneration. The transplanted 
tissue gave rise to mature photoreceptors and, in some cases, established synaptic 
connections with the host cells110 and recovered light responsiveness111. Retinal tissues 
generated from human ESC-derived organoids also survive, mature and demonstrate a 
degree of integration with the host tissue when transplanted into rat and primate models of 
retinal degeneration112. Intestinal organoids grown from dissociated mouse colon epithelia or 
from single stem cells and transplanted into mice were able to regenerate colonic mucosa 
injuries to various degrees113. Similarly, transplanted enterospheres grown from fetal 
intestinal progenitor cells integrate into injured mouse colon and differentiate in vivo46. 
Transplantation experiments in animal models have also been reported for liver57,80 and 
kidney48 organoids. Indeed, the ability of organoids to provide cells that are competent to 
reconstruct organ function and potentially also a niche that protects the graft from the hostile 
pathological environment could represent an advantage in cell therapy applications 
compared with transplantation of cells deprived of their physiological context. This 
hypothesis is supported by a study that reported that 3D-structured grafts integrate into the 
host mouse retina better than dissociated embryonic retinal progenitors110. 
Finally, the use of organoids for regenerative medicine could be used in combination with in 
vitro genetic correction strategies to enable the autologous replacement of tissues affected 
by genetic disorders. In a proof-of-principle study, CRISPR–Cas9-mediated gene editing was 
used to correct the most common CFTR mutation leading to CF, a deletion of phenylalanine 
at position 508, in patient-derived ISCs, which were then used to generate functional 
organoids114 (Fig. 3e). 
Although preliminary, taken together, these results are highly promising and indicate that the 
clinical transplantation of organoid-derived cells and tissues might be feasible. 
 
 
 
 
 
Towards a new generation of organoids 
 
The applications discussed above rely on the reproducible generation of organoids with a high 
level of structural and functional similarity with real organs to be used as faithful substitutes 
for in vivo studies. Although the organoid field is moving ahead at an impressive speed, 
bridging the gap with native organs will be the main challenge in the decades to come. A 
general limitation of all organoid derivation protocols is the high variability of the phenotypes 
that they can produce. Organoid-to-organoid reproducibility is a limitation for many 
applications but is particularly problematic for translational studies, such as drug screening, 
in which a high intrinsic variability could mask the effect of a treatment. Moreover, different 
types of organoids recapitulate with different accuracy the cellular and architectural 
complexity of their respective organ. This characteristic applies to the capacity of an organoid 
to reproduce all cell types within a specific tissue as well as the different tissues of an organ. 
For example, whereas intestinal organoids from ASCs are exclusively composed of intestinal 
epithelium13, derivation of intestinal organoids from PSCs can also give rise to the intestinal 
mesenchyme45. Another important limitation, especially for PSC-derived organoids, is their 
low grade of maturation, which hinders their application as models for adult tissue biology. 
Below, we discuss how progress in other disciplines could help overcome these shortcomings 
(Fig. 4). 
 
 
In-depth characterization of organoids. 
Organoids are complex structures composed of different cell types arranged in 3D space but, 
for most systems, the identity of these cell types has not been thoroughly defined. This makes 
it difficult to determine how accurately an organoid represents native organ composition and 
architecture. Single-cell sequencing technologies provide a powerful way to relate the 
transcriptional profiles of organoids to those of targeted organs. This approach not only 
provides information on cellular identities within organoids but also can help to define the 
lineage trajectories of selected cell types. This type of analysis has already been conducted 
for cerebral organoids115,116 and liver organoids117, which have been shown to have similar 
gene expression profiles to fetal neocortex and fetal liver, respectively. As a result of a multi-
laboratory project, stage-dependent transcriptome data from embryonic animal tissues are 
becoming available118, and this information will help reveal how faithfully organoids 
recapitulate developmental processes. Moreover, RNA tomography can generate cell 
transcriptional profiles with spatial resolution, thereby providing information on the position 
of different cell types within the organ architecture119. These impressive early efforts towards 
a deeper characterization of organoids will ultimately also contribute to the improved 
reproducibility of organoid cultures. 
 
Improved organoid maturation. 
As discussed above, a major shortcoming of PSC-derived organoids is their limited cell 
maturation. Indeed, organoids of this type usually resemble fetal tissues rather than adult 
ones. On the one hand, this might simply be due to the restricted lifespan of organoids, which 
limits their ability to reach later stages of development. On the other hand, it is possible that 
in vitro conditions lack specific in vivo environmental factors that promote organoid 
maturation. For example, brain organoids could require sensory stimulation for further 
maturation, which contributes to the shaping of neural circuits in vivo120. Lengthening the 
culture period is particularly crucial for human organoids because they take much longer than 
mouse organoids to reach comparable stages12,78. 
An obvious reason for the limited lifespan of organoids is that, once a certain size is reached, 
diffusion is unable to supply all the cells with sufficient nutrients to support continued 
development90. A possible solution to this problem could be the use of bioreactors that 
improve nutrient supply through constant culture spinning (Fig. 4a). Bioreactors are 
extensively applied in the field of tissue engineering to introduce controlled changes of 
culture conditions, standardize them and scale up tissue production for regenerative 
medicine121,122. Indeed, such bioreactors have extended the duration of brain organoid 
cultures from a couple of months to up to 1 year123 and have resulted in structures that more 
closely resemble the developing human brain. 
Vascularization of organoids could further improve their lifespan by distributing nutrients via 
capillaries, as occurs in vivo (Fig. 4b). Emerging bioengineering approaches that have been 
developed to generate vascularized tissue-like structures include sacrificial moulds124–126 and 
laser ablation127, which enable fabrication of channels within the culturing scaffold that can 
host endothelial cells and form perfusable vascular units. Alternatively, bioprinting 
methods128,129 have been used to control the position of endothelial cells in 3D-printed 
structures. Although these studies were conducted in simplified cellular systems, organoid 
culture could benefit from future improved versions of these methods. 
Another strategy to promote vascularization of the growing tissue would be to integrate 
endothelial cells, or their progenitors, during organoid formation. This approach has been 
successfully applied to liver organoids: human endothelial cells were co-cultured with human 
mesenchymal stem cells and human iPSC-derived hepatic endoderm cells to form self-
organizing liver buds with a microvascular network that rapidly connected to the host 
circulation upon transplantation into mice43 (Fig. 4f). Alternatively, the desired organ-specific 
cells and vascular endothelial cells can be independently differentiated from PSCs and the 
endothelial cells then used to vascularize the organoid, as has been shown for human brain 
organoids130. Recently, it has been demonstrated that hPSC-derived cerebral organoids 
implanted into mouse brains can be vascularized by the host131. Interestingly, the host-
vascularized organoid grafts survive for up to 233 days post-implantation and reach later stages 
of development than do stage-matched cerebral organoids cultured in vitro. They also have 
a higher number of mature neurons, mature astrocytes, microglia and cells expressing 
markers of dorso-cortical identity131. That organoids can acquire a more developed 
phenotype when transplanted in vivo has also been demonstrated for other organoids, such 
as liver43, intestine132 and lung133, which suggests that exposure to in vivo systemic factors 
and vascularization promotes the growth and maturation of organoids. Nevertheless, full 
maturation of some tissues may require many years in vivo, such as the cerebral cortex, which 
continues to develop postnatally. The full development of such adult traits may require 
innovative strategies that artificially accelerate maturation processes. For organoids obtained 
from patient iPSCs, the modelling of age-related phenotypes is even more challenging. 
Indeed, reprogramming of adult cells tends to erase the original age-related traits134. 
Although not extended to organoids, the transient overexpression of progerin (a truncated 
form of lamin A) in patient iPSCs has been used to recapitulate age-related traits and has 
allowed in vitro modelling of pathological features of Parkinson disease134. 
 
 
 
Improved organoid architecture. 
Self-organization can generate organoids with a 3D microanatomy that resembles that of in 
vivo organs, but their overall architecture usually differs greatly from real organs. To address 
this challenge, stem cell culture scaffolds with a topography matching that of a specific tissue 
could be used to improve organoid architecture and increase size. For example, 
microstructured collagen gels that mimic the typical crypt anatomy of the colonic epithelium 
have been used to culture a self-renewing monolayer of human colonic cells135, and an 
architecture that mimics the crypt–villus structure has been used to culture human small 
intestinal stem cells136. At the microscale, organoid topology could be improved by adopting 
bioengineering approaches to better regulate self-organization and morphogenesis (for 
instance, by precisely controlling interactions between stem cells and the surrounding ECM). 
Most organoid protocols use naturally derived hydrogel matrices such as Matrigel. Although 
these matrices are extremely effective at promoting cell growth and self-organization, they 
limit the ability to direct organoid morphogenesis because they are ill-defined, suffer from 
lot-to-lot variability and do not support controlled modifications. They also contain animal-
derived products, which are undesirable for clinical applications owing to risks of immunogen 
and pathogen transfer. To overcome these limitations, a wide range of synthetic, chemically 
defined hydrogels have been developed for 3D cell culture137–145, the chemical and physical 
properties of which can be controlled and optimized for specific purposes. Some of these 
materials have already proved their compatibility with specific organoids: cerebral organoids 
have been grown in hyaluronan-based hydrogels37 and self-organizing neural tube cysts have 
been grown in poly(ethylene glycol) (PEG)-based hydrogels72,73. Furthermore, human 
intestinal organoids grown on synthetic hydrogels have been successfully transplanted into 
mouse models of colonic mucosal wounds in proof-of-concept studies146. Recently, new 
hydrogel formulations have been developed for which the biochemical and biophysical 
properties can be modulated spatially and temporally36,147,148 (Fig. 4c), which potentially adds 
an interesting new layer of control over organoid morphogenesis. Indeed, it has been shown 
that the mechanical properties of synthetic hydrogels can be dynamically tuned to initially 
favour ISC expansion and subsequently trigger crypt emergence and give rise to fully 
developed intestinal organoids36 (Fig. 4c). 
Other tools used in bioengineering could also be exploited to increase the control over 
organoid morphogenesis and self-organization but have not yet been applied to studies 
directly related to organoids. Such tools include hydrogels that permit instantaneous 
orthogonal modification of their biochemical and mechanical properties147, which could be 
used to dynamically regulate organoid morphogenesis and progressively guide them towards 
a desired architecture (Fig. 4c). Another example is light-triggered photoablation127, which 
could be used to actively re-adapt the geometry of the matrix to control morphogenetic 
rearrangements and favour organoid growth. Alternatively, new chemically defined materials 
that mimic the viscoelastic behaviours of in vivo ECM149–151 could improve organoid growth 
by continuously reacting and re-adapting to morphogenetic processes without the need for 
external triggers. 
The ability to control how cells assemble (for instance, by positioning different cell types in 
conformations that bias cell type-specific spatial interactions) could also be used to extend 
the control over organoid self-organization (Fig. 4d). Bioprinting methods developed to pre-
establish the 3D spatial organization of cells into tissues could fit this purpose152, as could the 
more recently developed DNA-programmed assembly of cells (DPAC) approach, which 
exploits the complementarity of DNA oligonucleotides153. Moreover, DPAC has been used to 
pattern mouse embryonic fibroblast clusters in a gel, allowing for predictable folding of 
collagen scaffolds154, showing its potential to directly influence morphogenetic processes. 
Organoid morphogenesis is also likely to be improved by gaining better control over the 
spatial and temporal distribution of diffusible signalling molecules (Fig. 4e). Indeed, whereas 
in vivo cell fate patterning is influenced by spatially localized signalling centres, in vitro 
signalling molecules are typically presented in a uniform fashion. Bioengineering methods 
that rely on microfluidic devices155–157 or on local diffusion from microspheres158 have been 
developed to reproduce gradients of signalling molecules in both 2D156 and 3D 
cultures155,157,158. In the future, these technologies could be applied to better control cell fate 
patterning during organoid development. Alternatively, synthetic biology approaches could 
be used to re-engineer the genetic programmes underlying self-organization; in a 
demonstration of its feasibility, synthetic Notch receptors were used to direct mammalian 
cells into self-organized cell patterns159,160. 
Finally, mathematical modelling could also help to define which factors play a role in a specific 
self-organization process67,70. As discussed for the case of gastruloids, in silico models could 
predict the behaviour of an in vitro system upon exposure to specific stimulations67,70. This 
approach could help to identify in silico the best strategies to obtain a desired outcome. 
 
Approaches to improve organoids for disease modelling. 
Another limitation of organoids, particularly for disease modelling applications, is their 
inability to model multi-organ pathologies. Co-culturing approaches (Fig. 4f) could partially 
address this issue. An early example in this direction has been reported for hPSC-derived 
intestinal organoids and enteric neurons161. In this study, the authors observed that 
mutations in PHOX2B, a gene associated with Hirschsprung disease, limit the differentiation 
of the enteric neuronal population, resulting in poor development of the smooth muscle 
components associated with the intestinal organoid epithelium161. For those pathologies with 
a strong immune component, the inclusion of vascularized networks perfused with immune 
cells could be a good strategy. Moreover, current drug testing platforms could be improved 
by merging organoid cultures with organ-on-chip technologies162 to generate 3D systems that 
re-create the crosstalk between different organs (Fig. 4g). This approach could combine the 
advantages of the two systems, bridging the ability to have interconnected, minimal systems 
typical of organs-on-chip with the high in vivo faithfulness and functionality typical of 
organoids. Clearly, the use of structured organoids requires novel microchip concepts that 
could seamlessly integrate with the highly stereotypical organization of organoids. Another 
crucial aspect for drug screening and personalized medicine applications of organoids is the 
development of reliable assays with accurate readouts of effectiveness, such as the CTFR drug 
screening assay conducted on intestinal organoids79. Integration of biosensors into the 
culture system could provide dynamic, automated means to quantitatively measure 
physicochemical responses to drugs and to provide custom readouts for drug screening 
applications, similar to approaches already demonstrated for organ-on-chip technology163. 
 
 
Conclusions 
 
Organoids have the capacity to mimic specific aspects of the 3D architecture, cell type 
composition and functionality of real organs while maintaining the advantages of simplified 
and easily accessible cell culture models. As such, they hold great promise for a range of 
biological and biomedical applications. In studies of basic tissue and organ biology, the 
potential for exploiting organoids to recapitulate in vivo phenomena has already been clearly 
revealed. Perhaps the most exciting perspective in basic organoid research is the ability to 
study human development (and disease) without tissue accessibility constraints. However, 
although the use of organoids also addresses some ethical issues, the prospect of generating 
in vitro human embryo-like structures is not free from ethical concerns164–166. 
The path towards a broad-ranging translation of organoid technology into real-life preclinical 
and clinical applications is considerably more challenging. Nevertheless, as discussed above, 
studies are now emerging that demonstrate the potential of organoids in personalized 
medicine settings101,103, drug discovery99,105,106, regenerative medicine and gene therapy114, 
suggesting that more widespread adoption of organoids in these fields will become a reality 
in the coming decades. 
Much has already been achieved in revealing the amazing level of self-organization that stem 
cells can display when cultured under the appropriate 3D conditions and in expanding the list 
of organoid types. Groundbreaking explorative studies for the application of various organoid 
types have also been published. However, many limitations still exist. Major challenges 
include regulating self-organization to generate organoids that develop deterministically, 
robustly and to physiologically relevant shapes and sizes; prolonging organoid lifespan to 
create mature, functional tissues that reach homeostasis; and recapitulating multi-factorial 
pathologies by incorporating additional key tissue compartments of native organs (such as 
the vasculature or immune system). Overcoming these challenges will require a 
multidisciplinary approach, and lessons from the field of bioengineering are likely to be 
particularly impactful. 
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Table1 
 
TISSUE or ORGAN SOURCE TRANSLATIONAL APPLICATIONS TECHNOLOGICAL 
IMPLEMENTATION 
Neuroectoderm 
OPTIC CUP AND 
RETINA 
MOUSE PSCs12,110 
 
 
HUMAN PSCs78,112,167–169 
-Orthotopic transplantation of mouse retinal organoids in murine models 
of retinal degeneration110 
 
-Orthotopic transplantation of human retinal organoids in primate models 
of retinal degeneration112 
- 
CEREBRAL 
STRUCTURES 
(CEREBRAL 
NEOCORTEX, 
OLFACTORY BULB, 
HIPPOCAMPUS, 
HYPOTHALAMUS, 
MIDBRAIN 
STRUCTURES, 
CHOROID PLEXUS) 
MOUSE PSCs14,32 
 
PRIMATE PSCs170 
 
HUMAN PSCs14,32,39,90,99,171 
 
 
-Model of microcephaly from patient-derived hiPSC cerebral organoids32 
 
-Model of Zika virus infection on forebrain organoids90 
 
-Drug screening for Zika virus infection using forebrain organoids as 
models99 
 
-Use of standard bioreactors 
to obtain human cerebral 
organoids with extended 
lifespan32 
 
-Use of miniaturized spinning 
bioreactors (Spin-Omega) to 
obtain human forebrain,  
midbrain and hypothalamic 
organoids in a multiplexed 
fashion90 
 
-Use of a chemically-defined 
PLGA copolymer as scaffold to 
obtain elongated cerebral 
organoids171  
ADENOHYPOPHYSIS MOUSE PSCs172 -Ectopic transplantation in hypophysectomized mice172 - 
CEREBELLUM HUMAN PSCs38 - - 
 
 Endoderm 
GASTRIC FUNDUS HUMAN PSCs42 - - 
GASTRIC CORPUS MOUSE PSCs173 
 
MOUSE ASCs44 
 
MOUSE dissociated 
tissue44,55 
 
HUMAN dissociated tissue55 
 
 
-Human gastric organoids originated from 
tumour cells to model human gastric 
cancer55 
 
-Model of Helicobacter pylori infection in 
human gastric organoids to study 
pathogenetic mechanisms55 
- 
GASTRIC PYLORIC 
ANTRUM 
MOUSE PSCs173 
 
MOUSE ASCs54 
 
HUMAN PSCs33,42 
 
 
-Model of Helicobacter pylori infection in 
human gastric organoids to study 
pathogenetic mechanisms33 
- 
SMALL INTESTINE MOUSE ASCs13,36,174–176 
 
 
HUMAN PSCs45,46,146,177 
 
MOUSE dissociated tissue178 
 
HUMAN dissociated 
tissue36,114,136 
 
 
MOUSE dissociated foetal 
tissue46 
-Ectopic transplantation of mouse small 
intestinal organoids onto damaged mouse 
colonic epithelium174 
 
-hPSC-derived intestinal organoids to 
model congenital loss of intestinal 
enteroendocrine cells45 
 
 
 
 
 
-CRISPR-Cas9-mediated correction of CFTR 
in intestinal organoids derived from cystic 
fibrosis patients.  Development of an in 
vitro readout to evaluate the recovery of 
CFTR function114 
  
-Use of a synthetic chemically-defined hydrogel with tunable 
mechanical properties to support mouse and human 
intestinal organoid culture36 
 
-Micro-structured collagen scaffolds mimicking the small 
intestinal crypt-villus macro-architecture have been used to 
culture human intestinal epithelium starting from intestinal 
stem cells136 
COLON and/or 
LARGE INTESTINE 
MOUSE ASCs113 
 
 
 
HUMAN PSCs45,46,146,177 
 
HUMAN ASCs179 
 
MOUSE dissociated 
tissue13,178 
 
HUMAN dissociated 
tissue53,114,135 
 
 
 
 
 
 
MOUSE dissociated foetal 
tissue46 
-Orthotopic transplantation of mouse 
colon organoids to damaged mouse colonic 
epithelium113 
 
 
-hPSC-derived intestinal organoids to 
model congenital loss of intestinal 
enteroendocrine cells45 
 
 
 
 
 
 
-Human colon organoids obtained from 
tumour cells as models for human 
colorectal cancer53 
 
-CRISPR-Cas9-mediated correction of CFTR 
in intestinal organoids derived from cystic 
fibrosis patients.  Development of an in 
vitro readout to evaluate the recovery of 
CFTR function114 
 
 
-Transplantation of mouse intestinal 
progenitor organoids on damaged colonic 
epithelium46 
 
 
 
 
Use of a synthetic chemically-defined hydrogel to grow hPSC-
derived intestinal organoids in vitro and for their orthotopic 
transplantation on damaged mouse colonic epithelium146 
 
 
 
 
 
-Micro-structured collagen scaffolds resembling colonic 
crypts array macro-architecture have been used to culture 
self-renewing human colonic epithelium135  
LIVER MOUSE ASCs57 
 
 
HUMAN PSCs43 
 
 
 
HUMAN ASCs80 
-Transplantation of mouse liver organoids 
into mouse model of type I tyrosinemia57 
 
 
 
 
 
-Use of patient-derived liver organoids to 
model alpha1-antitrypsin deficiency and 
Alagille syndrome80 
 
 
 
Co-culture of hPSC-derived hepatic endodermal cells with 
human endothelial (HUVEC) and human mesenchymal stem 
cells allows for the formation of a more complete liver 
cytoarchitecture43 
PANCREAS MOUSE ASCs56 
 
MOUSE dissociated tissue56 
 
HUMAN dissociated 
tissue95,180 
 
 
MOUSE dissociated 
embryonic tissue47 
 
 
 
 
 
 
Comparison between mouse pancreatic 
organoids generated from normal, early 
neoplastic and tumoural cells have 
revealed new insights on genes involved in 
the progression of pancreatic ductal 
adenocarcinoma95 
- 
TRACHEA/BRONCHI 
(or UPPER AIRWAYS)  
MOUSE ASCs181,182 
 
HUMAN PSCs183,184 
 
 
HUMAN ASCs181 
 
 
 
Proof-of-principle experiment on patient 
hPSC-derived epithelial airways for cystic 
fibrosis drug screening183 
- 
  
Abbreviations: PSCs – Pluripotent Stem Cells; ASCs – Adult Stem Cells; PLGA – poly(lactide-co-glycolide); HUVEC – Human 
Umbilical Vein Endothelial Cells, CFTR - Cystic fibrosis transmembrane conductance regulator. 
 
PULMONARY 
ALVEOLUS 
MOUSE ASCs185,186 
 
HUMAN PSCs133,184,187 
 
HUMAN ASCs186 
- - 
THYROID MOUSE PSCs188 - - 
ESOPHAGUS MOUSE dissociated tissue189 - - 
PROSTATE MOUSE ASCs190,191 
 
HUMAN ASCs190,191 
 
MOUSE dissociated tissue191 
Genetically engineered mouse prostate 
organoids have been used to model 
prostate cancer190,191 
- 
FALLOPIAN TUBE HUMAN ASCs192 - - 
 
Mesoderm 
KIDNEY MOUSE PSCs48 
 
HUMAN PSCs40,41,48,193,194 
 
 
-Use of human kidney organoids for the 
evaluation of nephrotoxicity41,193,194 
 
-Use of CRISPR-Cas9 engineered human 
kidney organoids to model polycystic 
kidney disease194 
- 
Surface Ectoderm 
MAMMARY GLAND MOUSE ASCs49,163 
 
HUMAN ASCs34,195 
 
MOUSE dissociated 
tissue15,196 
 
 
 
Generation of a breast cancer organoid 
biobank195 
  
- 
TASTE BUD MOUSE ASCs51 - - 
SALIVARY GLAND MOUSE ASCs50,197,198 
 
 
HUMAN ASCs199 
Mouse salivary gland organoids have been 
used to expand in vitro gland stem cells 
that restored salivary function in murine 
models of hyposalivation50,197 
- 
Embryonic Organoids 
PRE-IMPLANTATION 
MODELS 
MOUSE PSCs61  - - 
EARLY POST-
IMPLANTATION 
MODELS 
MOUSE PSCs62 
 
HUMAN PSCs63,64 
- - 
GASTRULOIDS MOUSE PSCs65,66,69 
 
HUMAN PSCs67,68,70,71 
- - 
NEURAL TUBE MOUSE PSCs72,73 - Growth in chemically-defined synthetic 3D matrices73 
 
 
 
Fig. 1 | Overview of organoid derivation methods. a | The physical features of the culture environment are important to 
organoid development. The main types of culture environments are shown, together with examples of organoids that rely 
on them. b | Organoids can be formed from cell populations with different starting conditions. Examples of an organoid 
protocol starting from a single cell (intestinal organoids), a homogeneous multicellular ensemble (optic cup organoids) and 
a heterogeneous co-culture of different cell types (liver organoids) are shown. The initial conditions are aligned with 
different steps of organoid development. ASC, adult stem cell; ECM, extracellular matrix; PSC, pluripotent stem cell. c | The 
formation of a specific organoid depends on different degrees of system-autonomous endogenous signals and exogenously 
supplied signals. Mouse optic cup formation depends largely on endogenous signals (left). Derivation of kidney organoids 
initially relies on exogenous signals that induce the ureteric epithelium and the metanephric mesenchyme from human 
pluripotent stem cells (hPSCs); subsequent self-organization steps rely on endogenous signals (centre). The supply of 
specific exogenous signals is continuously required for hPSC-derived gastric organoids (right). The necessity for exogenous 
signals likely substitutes for missing cell types that are responsible for the production of these signals during in vivo 
organogenesis. 
 
Fig. 2 | Starting cell type determines organoid maturation level in vitro. The graph shows the level of organoid maturation 
(vertical axis) that can be achieved according to the cells of origin (horizontal axis). Cancer cell-derived tumouroids, which 
show adult neoplastic phenotypes, should be considered a special case. PSCs, pluripotent stem cells 
 
 
 
Fig. 3 | Key organoid applications. a | In basic research, organoids can be used to understand the principles of development, 
homeostasis and regeneration. b | Organoids derived from patient stem cells represent useful tools for the study of disease 
mechanisms because they replicate the complexity of the in vivo disease phenotype while still retaining the accessibility of 
in vitro systems. c | Organoid biobanks could be used to identify drugs effective against a broad spectrum of disease 
phenotypes. d | In personalized medicine, patient-specific organoids can help identify the best drug for each patient. e | 
Organoids derived from healthy donor cells, or from patients after genetic correction, can be used as a source of cells or 
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Fig. 4 | Bioengineering approaches to overcome key limitations of existing organoids. a | Bioreactors increase nutrient 
availability , which is usually limited by organoid size. b | The implementation of vascular networks in organoid culture could 
provide a near-physiological way to increase nutrient availability. c | The control of the extracellular environment provides 
ways to steer organoid growth and self-organization towards a desired architecture. Synthetic materials with time-
dependent (top) or spatiotemporally programmable (bottom) mechanical and biochemical properties are promising tools 
for this purpose. d | The controlled spatial arrangement of different stem and/or progenitor cells may allow for defined 
reciprocal intercellular interactions, extending control over organoid self-organization. e | Following principles of embryonic 
development, the control of cell differentiation in space and time can be directed in vitro by the implementation of signalling 
centres and concentration gradients of developmentally relevant molecules (morphogens). f | The co-culture of different 
cell types could allow for the formation and possibly the spatial self-organization of diverse tissues within a single organoid.  
g | Organoids could be integrated with ad hoc organ-on-chip technologies, allowing the connection and communication 
between multiple pre-formed ‘organs’.  
 
 
Glossary 
 
Organoids.  Stem cell-derived or progenitor cell-derived 3D structures that, on much smaller 
scales, re-create important aspects of the 3D anatomy and multicellular repertoire of their 
physiological counterparts and that can recapitulate basic tissue-level functions. 
 
Adult stem cells(ASCs). Somatic stem cells with the capacity to give rise to the terminally 
differentiated cells of the tissue in which they reside. 
 
Pluripotent stem cells (PSCs). Stem cells that have the capacity to give rise to all the cell types 
of the embryo proper. PSCs include embryonic stem cells and induced PSCs. 
 
Organ-on-chip. Microfluidic cell culture device that contains perfused chambers in which 
living cells are arranged to simulate tissue-level and organ-level physiology. 
 
Symmetry-breaking.  The first identifiable event that triggers the formation of an asymmetric 
system from an initially homogeneous (symmetric) state. 
 
Reaction-diffusion mechanisms. Mathematical models that describe the dynamics of pattern 
formation in terms of local production and diffusion of activators and inhibitors and their 
interactions. 
Bistability of regulatory networks.  The behaviour of biological systems in which positive and 
negative feedback between networks of regulatory elements results in only one of two 
mutually exclusive outcomes. 
 
Asymmetric cell division. The mechanism of cellular division by which the mother cell 
produces two daughter cells with different cell fates. 
 
Air–liquid interface. A method for cell culture that is typically used for epithelial 
cells and in which a porous filter is used to expose basal cell layers to the cell culture medium 
and external cell layers to the air. 
 
Morphogens. Biomolecules that act in a concentration-dependent manner to determine cell 
fate choices and tissue patterning in vivo. 
 
Neuroepithelium (NE). Derived from neuroectoderm, the ectodermal embryonic 
compartment that will give rise to the nervous system. From this epithelium, components of 
the sensory organs are also formed, as in the case of the eye. Can be considered a synonym 
of neuroectoderm. 
 
Neural retina (NR). A multi-layered structure of the eye formed by the neuronal types 
responsible for light acquisition and conversion into neural signals. 
 
Retinal pigmented epithelium (RPE). A pigmented epithelium attached to the outside of the 
neural retina in the eye. It provides nutritional support to neural retina cells. 
 
Ureteric epithelium. Derivative of the intermediate mesoderm that contributes to the 
formation of the renal collecting ducts. 
 
Metanephric mesenchyme. Derivative of the intermediate mesoderm that substantially 
contributes to the formation of the renal nephrons. 
 
Antral. The identity of the gastric epithelium in the most distal part of the stomach, pertaining 
to an anatomical region that connects to the intestinal duodenum called the pyloric antrum. 
 
Fundic. The identity of the gastric epithelium in the upper 
curvature of the stomach, pertaining to an anatomical region called the fundus of the 
stomach. 
 
Mesodermal. Derived from the mesoderm, the middle embryonic germ layer that is formed 
upon gastrulation and will give rise to different adult tissues such as skeletal and cardiac 
muscle, smooth muscle, blood, cartilage, bones and dermis. 
 
Surface ectoderm. The part of the embryonic ectoderm that lines the exterior of the embryo 
(the surface). Derivatives of the surface ectoderm include the epidermis with associated 
glands (including the mammary glands), sensory receptors, the epithelium of the oral and 
nasal cavity with associated glands and the cornea and the lens of the eye, among others. 
 
Glandular tissues. Epithelial tissues that produce and release biomolecules (hormones and 
growth factors, among others) into the bloodstream, in external or internal body cavities. 
 
Endodermal. Derived from the endoderm, the most inner embryonic germ layer formed upon 
gastrulation, that will give rise to internal structures such as the epithelial lining of the 
respiratory and gastrointestinal tracts and of the urinary system. 
 
Gastrulation. A process that occurs during mammalian embryonic development in which the 
three germ layers (ectoderm, mesoderm and endoderm) form from the epiblast and arrange 
in space to generate a more defined body plan of the organism. 
 
Enterospheres. Spherical epithelial cysts of fetal intestinal progenitors. 
 
Crypts. Invaginations of the intestinal epithelium at the base of villi, which typically host self-
renewing LGR5+ intestinal stem cells and Paneth cells at their bottom. 
 
Optic vesicles. Embryonic epithelial vesicles evaginating from the forebrain neuroepithelium 
that will give rise to the optic cup. In organoids, they are the vesicular structures forming at 
early stages of organoid development, before the morphological changes that will give rise to 
the final optic cup structure. 
 
Personalized medicine. A medical procedure in which the therapy and/or treatment is 
tailored to a specific patient. 
 
Organoid biobanks. Collections of organoid samples, typically of human origin, that are stored 
for research purposes and aim to encompass a wide range of population genetic variance. 
 
3R principles. A framework for more humane animal research aimed at replacing, reducing 
and refining animal experimentation. 
 
Bioreactors. Devices for the large-scale expansion of cells under controlled culture conditions. 
 
Sacrificial moulds. Templates used to form a structure; they are dissolved after the moulding 
process. 
 
Laser ablation. The controlled removal of portions of a material through irradiation with a 
laser beam. 
 
Bioprinting. The use of specialized 3D printing technologies to combine cells, biomolecules 
and biomaterials in 3D assemblies. 
 
Biosensors. Devices comprising biological components (such as antibodies and enzymes, 
among others) and electrochemical components for the measurement of biological 
parameters. 
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